Cancer stem cells as mediators of treatment resistance in brain tumors: status and controversies.
about
CD133 antigen expression in ovarian cancerCD133-positive hepatocellular carcinoma in an area endemic for hepatitis B virus infectionGlioma Stem Cells and Their Microenvironments: Providers of Challenging Therapeutic TargetsTransglutaminase is a tumor cell and cancer stem cell survival factorMicroRNAs are involved in the self-renewal and differentiation of cancer stem cellsThe potential origin of glioblastoma initiating cellsReinventing diagnostics for personalized therapy in oncologyCD133 is a marker of bioenergetic stress in human gliomaNeuroblastoma cell lines contain pluripotent tumor initiating cells that are susceptible to a targeted oncolytic virusCell separation: Terminology and practical considerations.Neoplasia: the second decade.Expression of the "stem cell marker" CD133 in pancreas and pancreatic ductal adenocarcinomas1-Oxoeudesm-11(13)-eno-12,8a-lactone induces G2/M arrest and apoptosis of human glioblastoma cells in vitro.Mesenchymal stem cells from human fat engineered to secrete BMP4 are nononcogenic, suppress brain cancer, and prolong survivalSulforaphane, a dietary component of broccoli/broccoli sprouts, inhibits breast cancer stem cellsIdentification of cell surface glycoprotein markers for glioblastoma-derived stem-like cells using a lectin microarray and LC-MS/MS approach.The dietary bioflavonoid quercetin synergizes with epigallocathechin gallate (EGCG) to inhibit prostate cancer stem cell characteristics, invasion, migration and epithelial-mesenchymal transition.Targeting stem cells-clinical implications for cancer therapy.Mesenchymal stem cells derived from adipose tissue vs bone marrow: in vitro comparison of their tropism towards gliomas.The changing role of pathology in breast cancer diagnosis and treatment.Targeting breast cancer-initiating/stem cells with melanoma differentiation-associated gene-7/interleukin-24.What Tumor Dynamics Modeling Can Teach us About Exploiting the Stem-Cell View for Better Cancer Treatment.Koenimbin, a natural dietary compound of Murraya koenigii (L) Spreng: inhibition of MCF7 breast cancer cells and targeting of derived MCF7 breast cancer stem cells (CD44(+)/CD24(-/low)): an in vitro study.Inconsistent immunohistochemical expression patterns of four different CD133 antibody clones in glioblastomaRadiosensitization of Primary Human Glioblastoma Stem-like Cells with Low-Dose AKT Inhibition.Implications of cancer stem cell theory for cancer chemoprevention by natural dietary compounds.The Role of Cancer Stem Cells in the Organ Tropism of Breast Cancer Metastasis: A Mechanistic Balance between the "Seed" and the "Soil"?ABT-263 induces apoptosis and synergizes with chemotherapy by targeting stemness pathways in esophageal cancer.Estradiol, TGF-β1 and hypoxia promote breast cancer stemness and EMT-mediated breast cancer migrationSca-1 identifies the tumor-initiating cells in mammary tumors of BALB-neuT transgenic mice.High-resolution magic angle spinning magnetic resonance spectroscopy detects glycine as a biomarker in brain tumors.Epigenetic regulation of miRNA-211 by MMP-9 governs glioma cell apoptosis, chemosensitivity and radiosensitivity.The controversial clinicobiological role of breast cancer stem cells.Implications of the cancer stem-cell hypothesis for breast cancer prevention and therapy.Origins and clinical implications of the brain tumor stem cell hypothesis.ABC transporter activity linked to radiation resistance and molecular subtype in pediatric medulloblastoma.B7-H4 expression is elevated in human U251 glioma stem-like cells and is inducible in monocytes cultured with U251 stem-like cell conditioned medium.The War on Cancer rages on.Applications of neural and mesenchymal stem cells in the treatment of gliomas.Anticancer activity of a monobenzyltin complex C1 against MDA-MB-231 cells through induction of Apoptosis and inhibition of breast cancer stem cells
P2860
Q21093306-B77315CD-CAC5-4733-A5C2-235F37709C77Q24645322-201818BE-D510-41D3-9189-D0B6A8C2656EQ26765758-47CDF509-5136-4B47-A533-C783B4911324Q26799862-8B0E062A-396F-45D8-8EBB-C555E788E9E0Q26828793-65B95E8D-524F-4FEF-A14D-B70793AA3FF6Q27005807-1FD31C54-7D67-4E04-9581-201334B0786AQ28391395-720988E3-FB00-4E2D-876C-669E716076A1Q28473995-C273702A-6BA7-4F4D-9B18-E631052D071FQ28474594-0CF88FEE-DE49-4E25-9181-42A618A313FDQ30458000-D15A8411-C8DD-482B-8B5B-FCE243CCF757Q30484000-CD9C4C4E-20D2-486A-B857-4021BB08AF6CQ33318981-9B6590AF-0AF4-4383-A96E-1B19A4344D0BQ33572361-36F339C9-E0D4-43A9-9872-A157794645D4Q33728678-3E73C293-093D-4C58-8E94-0BA39BEDF0A8Q33820656-4DEA632A-3007-4CE7-9AFD-9D37719B76CCQ33835228-8FFCC333-1D3C-4423-8351-BF035464BA80Q34105402-2E5B45F7-5B3B-4E75-AA7B-F96C7CDC39FFQ34555251-4B406DE4-4777-4A57-8212-3F065E10E26FQ34647951-029C87DE-EAEE-4711-BF6D-5D16D37E3015Q35082260-E28DF580-5E56-4EE0-BD1E-99B7D13FB541Q35101122-5EBA7230-720E-4503-9752-1A207B647173Q35135634-72AC7098-9B79-44A9-9420-5FFE3F3D0C00Q35136175-AEB0E301-D11B-48D7-A114-5A8B3764C490Q35440815-86B30369-0EF5-4AEE-8DA0-9727966C9309Q35587475-8A1D710A-91E4-458C-87FB-D43E970F0D47Q35642514-7E9E43C9-224F-4C1F-B90A-23BAFCB1193AQ35684577-F1CB10A9-E6D5-496D-B685-7EAE18BE45B0Q36413318-56E98A33-036D-4D9A-A220-576222E0B3E6Q36640378-5AE4A427-8FA2-4247-9A7D-C2C2FF6E4B4AQ36982130-3A59B856-4244-45B2-9E75-1499EBD10AE3Q37024727-67522EFA-D800-49F2-801D-8F685C95CAE2Q37030916-52647EAD-E9C5-4202-A921-1C21AB0B810FQ37134143-940FDB32-916B-4730-B1BA-D0EF321C564AQ37186412-29BC5A27-3920-4DDB-982F-1B9A16D6149AQ37230949-B9FD5C78-2197-461A-B41E-9612DBA976AAQ37365043-62A89553-BE21-4770-ADEB-0913C6785CD1Q37409770-0423C1F3-3816-461E-9E57-89E881917AF7Q37478602-49CAED41-866D-4761-B528-133896800A31Q37483966-AB4D8503-8251-429B-A8FC-23949AB5E959Q37504822-5B073BB1-A887-4E3B-A286-15D109A1F369
P2860
Cancer stem cells as mediators of treatment resistance in brain tumors: status and controversies.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Cancer stem cells as mediators ...... ors: status and controversies.
@en
Cancer stem cells as mediators ...... ors: status and controversies.
@nl
type
label
Cancer stem cells as mediators ...... ors: status and controversies.
@en
Cancer stem cells as mediators ...... ors: status and controversies.
@nl
prefLabel
Cancer stem cells as mediators ...... ors: status and controversies.
@en
Cancer stem cells as mediators ...... ors: status and controversies.
@nl
P2093
P2860
P356
P1433
P1476
Cancer stem cells as mediators ...... ors: status and controversies.
@en
P2093
Heike Immervoll
Martha Chekenya
Per Ø Sakariassen
P2860
P304
P356
10.1593/NEO.07658
P577
2007-11-01T00:00:00Z